The document discusses practical patterns for myopia control, highlighting the effectiveness of atropine eye drops and behavioral modifications such as increased outdoor activities and reduced screen time. It emphasizes the impact of the COVID-19 pandemic on myopia progression in children, with a systematic review demonstrating a correlation between reduced outdoor time and increased myopia. Various dosages of atropine are examined, with recommendations for further clinical trials to establish optimal concentrations for myopia management.